atenolol has been researched along with Lung Diseases, Interstitial in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassen, R | 1 |
| Lena, H | 1 |
| Briens, E | 1 |
| Drenou, B | 1 |
| Delaval, P | 1 |
1 other study available for atenolol and Lung Diseases, Interstitial
| Article | Year |
|---|---|
[Interstitial pneumopathy caused by atenolol: a new case].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Lung Diseases, Interstitial; Male | 1997 |